Details
Title
Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor
Author
Karimi, Leena 1 ; Alves, Carla L 1 ; Terp, Mikkel G 1 ; Tuttolomondo, Martina 1 ; Portman, Neil 2 ; Ehmsen, Sidse 3 ; Johansen, Lene E 1 ; Bak, Martin 4 ; Lim, Elgene 2 ; Ditzel, Henrik J 5
1 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
2 Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
3 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark
4 Department of Pathology, Sydvestjysk Sygehus, Esbjerg, Denmark
5 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
1 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark
2 Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales Sydney, Sydney, New South Wales, Australia
3 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark
4 Department of Pathology, Sydvestjysk Sygehus, Esbjerg, Denmark
5 Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark; Department of Oncology, Institute of Clinical Research, Odense University Hospital, Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, Odense, Denmark
Pages
720-725
Section
LETTERS TO THE EDITOR
Publication year
2023
Publication date
Jun 2023
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2824740772
Copyright
© 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.